ReviewFrontiers in pharmacology2021

CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy.

Christopher R Veitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.